Emma Koehn
Journalist at Freelance
Journalist, writer, researcher, film-watcher. Previously at @theage @smh @smartcompany and elsewhere
Articles
-
1 week ago |
thelimbic.com | Emma Koehn
The BMJ’s gastroenterology and hepatology journal Gut has retracted a research letter on early gastric cancer detection, alleging “manipulation” of the peer review process. The journal posted a retraction of the piece, titled “Unleashing the potential of exosome ncRNAs for early gastric cancer detection—a critical appraisal of machine learning approaches”, on June 17. “This letter has been retracted by Gut due to apparent peer review manipulation,” the journal said [link here].
-
1 week ago |
thelimbic.com | Emma Koehn
Australia’s medical community backed the importance of price transparency as the sector digested a blistering report on the costs of specialist care, but responses to the analysis highlighted the complexities of unwinding current barriers to access. The price of medical consultations was once again thrust into the spotlight after The Grattan Institute think tank released a comprehensive five-pronged blueprint [link here] to overhaul specialist service delivery in Australia.
-
2 weeks ago |
thelimbic.com | Emma Koehn
Patients aged over 50 should be regularly screened for natriuretic peptides (NPs) to detect early heart failure, and regular monitoring should become as standard as LDL cholesterol testing, according to one European cardiology expert.
-
1 month ago |
thelimbic.com | Emma Koehn
The incidence of congenital abnormalities is relatively low following the use of GLP-1RAs in early pregnancy, although knowledge gaps must be addressed before the drugs can be recommended as safe, a review suggests. The study evaluated clinical reviews data for every GLP-1RA drug trial reported to the US Food and Drug Administration to track the number of pregnancies occurring during clinical development programs.
-
1 month ago |
thelimbic.com | Emma Koehn
Apixaban is associated with a significantly lower risk of recurrent VTE and major bleeding compared with rivaroxaban or warfarin, a study of more than 160,000 patients suggests. The results of the multi-cohort study of US patients who had VTE between 2016 and 2024 support the use of oral anticoagulants as a primary treatment to prevent the recurrence of clots and suggests that apixaban is the safest and most effective choice for most individuals, the researchers said.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →Coverage map
X (formerly Twitter)
- Followers
- 1K
- Tweets
- 1K
- DMs Open
- Yes
Solidarity with these incredibly hardworking people - they deserve to be paid fairly. #DontTorchJournalism
#MEAAmedia members at @theage are now on strike! Come down and show your support at their Docklands building. #DontTorchJournalism https://t.co/lDK7Sqmy4J
RT @withMEAA: Journalists at @sydneymorningherald , @theageaustralia, @financialreview, @brisbane_times and @watoday are on strike until 11…
RT @withMEAA: Freelancers are standing with staff today to demand that Nine comes to the table with a good offer for all workers. Freelance…
